Exparel 266 MG/20 ML vial 20ML
Ended Awarded
- Contract number
- SPE2DR26FGEN2
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,623
Award facts
- Contract value 100% obligated
- $25,622.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $25,622.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. The delivery order, issued on November 18, 2025, with an ultimate completion date of December 10, 2025, was awarded without set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's recently awarded single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR, which carries a $499,999,999 ceiling value and extends through December 31, 2036.
EXPAREL, a specialty surgical anesthetic product, aligns with DMS Pharmaceutical Group's established portfolio of specialty pharmaceuticals and surgical products supplied to Department of Defense healthcare facilities. The PPV-G GEN V program represents a $30.3 billion acquisition strategy designed to provide the military medical system with comprehensive pharmaceutical and medical consumable support globally. DMS Pharmaceutical Group's demonstrated performance across numerous delivery orders spanning diverse therapeutic categories positions the company as a critical supplier within the federal military medical supply chain, with this order representing one of multiple awards issued to the contractor by the Defense Logistics Agency's Medical Supply Chain division in recent months.
Quick answers
Who was awarded contract SPE2DR26FGEN2?
SPE2DR26FGEN2 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on November 18, 2025.
How much is contract SPE2DR26FGEN2 worth?
The government has obligated $25,623 on SPE2DR26FGEN2.
Is contract SPE2DR26FGEN2 an order under another contract?
Yes. SPE2DR26FGEN2 is a delivery order under SPE2DR25D9312, an indefinite delivery contract.
Was contract SPE2DR26FGEN2 competed?
The extent of competition for SPE2DR26FGEN2 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award